Fredrik Mertens

Active 1987–2024

132
Papers
27,967
Citations
90
h-index
130
i10-index

Citations

Citations per year for Fredrik Mertens1967: 1 citations1988: 7 citations1989: 3 citations1990: 3 citations1991: 6 citations1992: 9 citations1993: 8 citations1994: 18 citations1995: 28 citations1996: 33 citations1997: 58 citations1998: 68 citations1999: 91 citations2000: 124 citations2001: 141 citations2002: 142 citations2003: 133 citations2004: 142 citations2005: 148 citations2006: 137 citations2007: 174 citations2008: 179 citations2009: 205 citations2010: 204 citations2011: 188 citations2012: 215 citations2013: 241 citations2014: 274 citations2015: 253 citations2016: 234 citations2017: 190 citations2018: 128 citations2019: 584 citations2020: 596 citations2021: 473 citations2022: 315 citations2023: 267 citations2024: 439 citations2025: 183 citations2026: 2 citations1968–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,341 citing papers, 29.8% of this breakdownChina: 532 citing papers, 6.8% of this breakdownUnited Kingdom: 515 citing papers, 6.6% of this breakdownGermany: 473 citing papers, 6% of this breakdownFrance: 386 citing papers, 4.9% of this breakdownItaly: 386 citing papers, 4.9% of this breakdownNetherlands: 325 citing papers, 4.1% of this breakdownSweden: 301 citing papers, 3.8% of this breakdownCanada: 287 citing papers, 3.7% of this breakdownJapan: 270 citing papers, 3.4% of this breakdownSpain: 176 citing papers, 2.2% of this breakdownSwitzerland: 157 citing papers, 2% of this breakdown
0%29.8%Other 21.8%

Fields

  • Medicine63.3%
  • Biochemistry, Genetics and Molecular Biology32.4%
  • Immunology and Microbiology2.3%
  • Agricultural and Biological Sciences0.6%
  • Computer Science0.3%
  • Neuroscience0.2%
  • Other0.9%

Topics

  • Sarcoma Diagnosis and Treatment9.8%
  • Cancer Genomics and Diagnostics4.4%
  • Bone Tumor Diagnosis and Treatments3.5%
  • Soft tissue tumor case studies2.2%
  • Glioma Diagnosis and Treatment2%
  • Genomic variations and chromosomal abnormalities2%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Signatures of copy number alterations in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 516

  2. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Zhang, Roger E. McLendon, Darell D. Bigner, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 1,375

  3. Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

    Authors: , , , , , , , , , , - Clinical Cancer Research 2011 cited by 510

  4. The emerging complexity of gene fusions in cancer

    Authors: , , , - Nature reviews. Cancer 2015 cited by 699

  5. The impact of translocations and gene fusions on cancer causation

    Authors: , , - Nature reviews. Cancer 2007 cited by 1,419

  6. Signatures of copy number alterations in human cancer

    Authors: , , , , , , , , , , , , - 2021 cited by 58

  7. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Authors: , , , , , , , , , , , , , , , , - Oncogene 2001 cited by 622

  8. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

    Authors: , , , , - Modern Pathology 2013 cited by 773

  9. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

    Authors: , , , , , , , , , - Neuro-Oncology 2012 cited by 277

  10. HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions

    Authors: , , , , , , , , , , , , , , , , - Leukemia 2021 cited by 88

  11. Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes

    Authors: , , - Genes Chromosomes and Cancer 2015 cited by 141

  12. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 433

  13. Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data

    Authors: , , , , , , , , , , , , , - Genes Chromosomes and Cancer 2011 cited by 341

  14. Activation of the GLI Oncogene through Fusion with the β-Actin Gene (ACTB) in a Group of Distinctive Pericytic Neoplasms

    Authors: , , , , , , , , , , , - American Journal Of Pathology 2004 cited by 176

  15. Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monica Nistér, Fredrik Mertens, Magnus Sabel, Ulrika Norén‐Nyström, Pernilla Grillner, Ann Nordgren, Gustaf Ljungman, Johanna Sandgren, David Gisselsson, for the Genomic Medicine Sweden Childhood Cancer Working Group - JCO Precision Oncology 2023 cited by 31

  16. Pathology and genetics of tumours of soft tissue and bone

    Authors: , , - IARC Press eBooks 2002 cited by 2,075

  17. Abnormal Nuclear Shape in Solid Tumors Reflects Mitotic Instability

    Authors: , , , , , , - American Journal Of Pathology 2001 cited by 212

  18. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

    Authors: , , , , , , , , , , , , , , - Genes Chromosomes and Cancer 2013 cited by 277

  19. MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma

    Authors: , , , , , , , - The American Journal of Surgical Pathology 2012 cited by 263

  20. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes

    Authors: , , , , , , , , , , , , - Genes Chromosomes and Cancer 2012 cited by 151

  21. Germline and somatic NF1 mutations in sporadic and NF1‐associated malignant peripheral nerve sheath tumours

    Authors: , , , , , , , - The Journal of Pathology 2008 cited by 120

  22. Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets

    Authors: , , , , , , , , , , , , , , , - EBioMedicine 2023 cited by 27

  23. TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura D. Wood, M. Zhang, Patrick Healy, Rui Yang, Bill H. Diplas, Z. H. Wang, Paula K. Greer, Huishan Zhu, C. Wang, Austin B. Carpenter, James E. Herndon, Roger E. McLendon, K. W. Kinzler, Bert Vogelstein, Nikolaos G. Papadopoulos, D D Bigner - Neuro-Oncology 2014 cited by 533

  24. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer

    Authors: , , - Nature Genetics 2004 cited by 362